Holdings

Superstring Capital Management LP

As of Sep 30, 2026, Superstring Capital Management LP reported 33 positions worth US$190M. Largest: Cogent Biosciences, Inc., Axsome Therapeutics, Inc. and Trevi Therapeutics, Inc. What it bought and sold, with each filing.

CompanySharesValue as reportedChangeAs of
Cogent Biosciences, Inc.597KUS$19.1M+254KSep 30, 2026
Axsome Therapeutics, Inc.102KUS$18.9M+48,569Sep 30, 2026
Trevi Therapeutics, Inc.985KUS$14.1M+461KSep 30, 2026
Genmab A/S366KUS$13M−64,938Sep 30, 2026
Climb Bio, Inc.918KUS$10.5M+397KSep 30, 2026
Zai Lab Ltd.363KUS$9.55M+207KSep 30, 2026
Adlai Nortye Group Ltd.588KUS$9.41MnewSep 30, 2026
Revolution Medicines, Inc.41,784US$8.58M−9,269Sep 30, 2026
Celldex Therapeutics, Inc.242KUS$7.86M−45,090Sep 30, 2026
Immunovant, Inc.222KUS$7.5M+13,753Sep 30, 2026